Collectively, these results clearly demonstrate that sh-Cxcl3 inhibits PMN-MDSC infiltration and promotes CD8+ T-cell accumulation and antitumor function in CRC, thus inhibiting the progression of CRC. This evidence concerns the gene CXCL3 and colorectal carcinoma.